Literature DB >> 4028036

Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.

S M Grunberg, R A Kempf, L M Itri, C L Venturi, W D Boswell, M S Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4028036

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.

Authors:  M Higashiyama; R Hokari; C Kurihara; T Ueda; M Nakamura; S Komoto; Y Okada; C Watanabe; A Kawaguchi; S Nagao; S Miura
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

2.  Cardiovascular rhythm effects of gamma recombinant DNA interferon.

Authors:  G G Friess; T D Brown; R C Wrenn
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

Review 3.  The role of interferons in the treatment of malignant neoplasms.

Authors:  J R Murren; A C Buzaid
Journal:  Yale J Biol Med       Date:  1989 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.